Conduit Pharmaceuticals (CDT) Stock Chart & Stock Price History $0.06 +0.00 (+8.44%) (As of 12/24/2024 05:19 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Conduit Pharmaceuticals Stock Price Performance 5 Day Performance-20.88%1 Month Performance-36.79%3 Month Performance-54.11%6 Month Performance-94.42%Year-To-Date Performance-98.70%1 Year Performance-98.83% Receive CDT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Conduit Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address [PDF] The Opportunity in Gold (Ad)Commodities expert, Geof Smith, insists that the supercycle on gold is just getting warmed up. In fact, even though gold looks like this since he initially called a major bull run 11 months ago… He’s still predicting it will be the TOP trade of 2025. His free eBook explains why You see, the last time gold launched into a supercycle like this it surged 536% The time before that was over 1,000%... That’s why Geof released this urgent guide to help you. Most people think they’ve missed out, but he thinks we’re at the very beginning of what could be the largest gold rally of our lifetimes. But, believe it or not, Geof doesn’t think you should just buy and hold precious metals. He’ll share more about his approach inside the eBook and it might surprise you.Tap here to read it CDT Stock Chart for Thursday, December, 26, 2024 CDT Chart by TradingView Conduit Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/25/2024$0.06$0.06$0.06$0.056.42 million shs$6.08 million12/24/2024$0.05$0.06+8.44%$0.06$0.056.42 million shs$6.08 million12/23/2024$0.07$0.05-27.04%$0.06$0.0519.44 million shs$5.61 million12/20/2024$0.07$0.07+13.87%$0.08$0.0618.69 million shs$7.68 million12/19/2024$0.07$0.07-7.61%$0.07$0.0612.62 million shs$6.75 million12/18/2024$0.08$0.07-10.01%$0.08$0.0715.99 million shs$7.30 million Get the Latest News and Ratings for CDT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Conduit Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/17/2024$0.07$0.08+6.77%$0.09$0.0724.15 million shs$8.12 million12/16/2024$0.08$0.07-9.33%$0.08$0.078.27 million shs$7.60 million12/13/2024$0.08$0.08-0.61%$0.08$0.0811.29 million shs$8.38 million12/12/2024$0.09$0.08-7.13%$0.11$0.08118.38 million shs$8.43 million12/11/2024$0.09$0.09-6.06%$0.09$0.093.23 million shs$9.08 million12/10/2024$0.09$0.09+4.10%$0.10$0.094.95 million shs$9.67 million12/09/2024$0.09$0.09-3.01%$0.09$0.093.89 million shs$9.29 million12/06/2024$0.09$0.09-1.69%$0.10$0.093.82 million shs$9.58 million12/05/2024$0.10$0.09-1.76%$0.10$0.093.04 million shs$9.74 million12/04/2024$0.10$0.10-0.52%$0.10$0.105.43 million shs$9.92 million12/03/2024$0.11$0.10-8.06%$0.10$0.094.51 million shs$9.97 million12/02/2024$0.11$0.11-1.50%$0.12$0.108.40 million shs$10.84 million11/29/2024$0.10$0.11+7.67%$0.11$0.109.29 million shs$10.97 million11/28/2024$0.10$0.10$0.11$0.0915.04 million shs$10.19 million11/27/2024$0.09$0.10+5.99%$0.11$0.0915.04 million shs$10.19 million11/26/2024$0.09$0.09+2.75%$0.10$0.0912.24 million shs$9.62 million11/25/2024$0.10$0.09-12.50%$0.10$0.0912.42 million shs$9.36 million Related Companies NKGen Biotech Stock Price Chart iBio Stock Price Chart Equillium Stock Price Chart Mannatech Stock Price Chart Pulmatrix Stock Price Chart NanoViricides Stock Price Chart Citius Pharmaceuticals Stock Price Chart GeoVax Labs Stock Price Chart MiNK Therapeutics Stock Price Chart Athira Pharma Stock Price Chart Receive CDT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Conduit Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CDT) was last updated on 12/26/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Conduit Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Conduit Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
